


Biokin:BL-B01D1 has been formally accepted for review.

BrightGene:BGM0504 has been formally accepted for review.

Alphamab Oncology:Anbenitamab is planned to be submitted for marketing approval.

Akeso:Gumokimab was approved

MSD:ENFLONSIAClesrovimab approved for marketing in China.

How much does SPINRAZA (Nusinersen Sodium Injection) Cost& price without insurance in China?

How much does URECE (Dotinurad Tablets) Cost& price without insurance in China?

How much does EYLEA (Aflibercept Intravitreal Solution) Cost& price without insurance in China?

How much does ZEPZELCA (Lurbinectedin for Injection) Cost& price without insurance in China?

How much does Huatangning (Dorzagliatin Tablets) Cost& price without insurance in China?

